| 2008-10-01 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 4,253 0.0027% | $32.65 | $138,860 | -6.88% | |
| 2008-09-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 6,614 0.0046% | $26.23 | $173,485 | +11.49% | |
| 2008-09-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 6,612 0.0046% | $25.86 | $170,986 | +13.11% | |
| 2008-08-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 6,612 0.0047% | $27.02 | $178,656 | +9.1% | |
| 2008-08-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 6,612 0.0049% | $27.57 | $182,302 | +11.3% | |
| 2008-05-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 80 <0.0001% | $27.89 | $2,231 | +11.18% | |
| 2008-05-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Dev. Group & CMO | 722 0.0005% | $27.59 | $19,918 | +5.48% | |
| 2007-12-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 480 0.0004% | $25.62 | $12,298 | +4.25% | |
| 2007-11-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 1 <0.0001% | $25.82 | $26 | +1.94% | |
| 2007-08-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 30,720 0.0231% | $35.00 | $1.08M | -25.92% | |
| 2007-05-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 794 0.0006% | $31.95 | $25,368 | -15.96% | |
| 2007-05-07 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 32,500 0.0253% | $30.59 | $994,175 | -13.25% | |
| 2007-01-31 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev., & CMO | 1,500 0.0012% | $35.46 | $53,190 | -14.85% | |
| 2007-01-24 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Med. Product Dev. & CMO | 1,500 0.0012% | $36.20 | $54,300 | -16.16% | |
| 2007-01-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev., & CMO | 1,500 0.0012% | $38.29 | $57,435 | -19.42% | |
| 2007-01-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev., & CMO | 1,500 0.0012% | $35.00 | $52,500 | -13.18% | |
| 2007-01-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP, Drug Eval. & Appr. | 1,500 0.0012% | $37.28 | $55,925 | -16.07% | |
| 2006-12-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP, Drug Eval. & Appr. | 1,500 0.0013% | $37.56 | $56,340 | -16.53% | |
| 2006-12-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP, Drug Eval. & Appr. | 1,500 0.0013% | $37.78 | $56,670 | -16.15% | |
| 2006-12-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Medicines Dev. & CMO | 1,980 0.0017% | $38.62 | $76,458 | -18.71% |